Roundup

Five things for pharma marketers to know: Friday, March 22, 2019

By

Alison Kanski

Publish Date March 22, 2019

Biogen ends Alzheimer’s trials; CVS starts selling CBD products; 70% say government spends too little on healthcare.

Five things for pharma marketers to know: Thursday, March 21, 2019

By

Carrie Gavit

Publish Date March 21, 2019

Novo submits diabetes pill for ‘priority review’; Top FDA compounding staffer to exit; Roman launches women’s product

Five things for pharma marketers to know: Wednesday, March 20, 2019

By

Alison Kanski

Publish Date March 20, 2019

Sanofi begins CEO succession plan; FDA places partial hold on Venclexta cancer trials; One-third of uninsured patients reduce costs by not taking medicine as prescribed.

Five things for pharma marketers to know: Tuesday, March 19, 2019

By

Alison Kanski

Publish Date March 19, 2019

Apple Watch warns 0.5% of users; Amarin’s Vascepa also helps prevent second and third heart attacks; Ohio sues OptumRx for overcharging for drugs.

Five things for pharma marketers to know: Monday, March 18, 2019

By

Alison Kanski

Publish Date March 18, 2019

FDA fast-tracks Purdue opioid-overdose treatment; India tries to block Juul’s entry into the country; Gottlieb calls on industry to adopt modernized clinical-trial approaches.

Five things for pharma marketers to know: Friday, March 15, 2019

By

Carrie Gavit

Publish Date March 15, 2019

Jury awards $29 million in J&J talc case; Mental health disorders linked to social media; The rundown on Haven.

Five things for pharma marketers to know: Thursday, March 14, 2019

By

Carrie Gavit

Publish Date March 14, 2019

FDA proposes more e-cigarette regulations; Congress invites PBMs to Hill; Novo, AstraZeneca pull ads from Fox News.

Five things for pharma marketers to know: Wednesday, March 13, 2019

By

Alison Kanski

Publish Date March 13, 2019

National Cancer Institute head named acting FDA chief; United Health plans to pass PBM rebates to consumers; Drug prices tally biggest one-month drop ever in February.

Five things for pharma marketers to know: Tuesday, March 12, 2019

By

Frank Washkuch

Publish Date March 12, 2019

Trump budget includes e-cigarette “user fee;” 23andMe to test for type 2 diabetes; FDA approves expanded use of Regeneron-Sanofi eczema drug.

Five things for pharma marketers to know: Monday, March 11, 2019

By

Frank Washkuch

Publish Date March 11, 2019

The latest from South by Southwest; Feds investigate new Shkreli reports; Roche wins FDA approval of Tecentriq to treat aggressive breast cancer.

Five things for pharma marketers to know: Friday, March 8, 2019

By

Frank Washkuch

Publish Date March 8, 2019

Juul pitches itself as smoking-cessation company; Shkreli plans a comeback; What’s next for the FDA?

Five things for pharma marketers to know: Thursday, March 7, 2019

By

Carrie Gavit

Publish Date March 7, 2019

Amazon names its healthcare venture Haven; BMS urges investors to back Celgene deal; Advisory council wants Canadian national drug agency; The latest edition of The MM&M Podcast.

Five things for pharma marketers to know: Wednesday, March 6, 2019

By

Carrie Gavit

Publish Date March 6, 2019

Gottlieb to quit FDA; Five of pharma’s top digital innovators; Matter launches dedicated healthcare shop.

Five things for pharma marketers to know: Tuesday, March 5, 2019

By

Frank Washkuch

Publish Date March 5, 2019

MM&M/Deloitte survey finds 26% jump in healthcare marketing budgets; Purdue considers Chapter 11; FDA slams retailers for teen tobacco sales.

Five things for pharma marketers to know: Monday, March 4, 2019

By

Frank Washkuch

Publish Date March 4, 2019

Karen Newmark on bringing her marketing background to POC; Schiff calls out Amazon over vaccine content; CVS closes hearing centers.